HLA types in patients with rheumatoid arthritis developing leucopenia after both gold and sulphasalazine treatment.
HLA types, especially HLA-DR3, are associated with the development of toxic reactions in patients with rheumatoid arthritis after treatment with gold or D-penicillamine. In this study, after treatment with sulphasalazine, leucopenia was observed in three patients, who all had a history of leucopenia...
Guardat en:
| Publicat a: | Ann Rheum Dis |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
1989
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1003812/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2570550/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.48.7.539 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|